Background: In recent years, being a kind of immune therapeutic form, hepatitis B immune ribonucleic acid (iRNA) has drawn a great attention in treatment of chronic hepatitis B. But its clinical effects are not stable, for which, it is significant to construct iRNA carrier system that can not only protect RNA effectively, but also be well absorbed by tissues. Being a kind of new supplementary material, chitosan has provided good results. Objective: To observe the immune activity of anti-hepatitis B iRNA by preparing its chitosan nanocarrier. Me...